Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional

Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma

ClinicalTrials.gov ID: NCT03854474

Public ClinicalTrials.gov record NCT03854474. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma

Study identification

NCT ID
NCT03854474
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
30 participants

Conditions and interventions

Interventions

  • Biospecimen Collection Procedure
  • Computed Tomography Procedure
  • Magnetic Resonance Imaging Procedure
  • Pembrolizumab Biological
  • Tazemetostat Drug

Procedure · Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2019
Primary completion
Jun 29, 2026
Completion
Jun 29, 2026
Last update posted
May 12, 2026

2019 – 2026

United States locations

U.S. sites
33
U.S. states
10
U.S. cities
31
Facility City State ZIP Site status
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054
Mayo Clinic in Arizona Scottsdale Arizona 85259
Smilow Cancer Hospital-Derby Care Center Derby Connecticut 06418
Smilow Cancer Hospital Care Center-Fairfield Fairfield Connecticut 06824
Smilow Cancer Hospital Care Center - Guilford Guilford Connecticut 06437
Smilow Cancer Hospital Care Center at Saint Francis Hartford Connecticut 06105
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510
Yale University New Haven Connecticut 06520
Yale-New Haven Hospital North Haven Medical Center North Haven Connecticut 06473
Smilow Cancer Hospital-Orange Care Center Orange Connecticut 06477
Smilow Cancer Hospital-Torrington Care Center Torrington Connecticut 06790
Smilow Cancer Hospital Care Center-Trumbull Trumbull Connecticut 06611
Smilow Cancer Hospital-Waterbury Care Center Waterbury Connecticut 06708
Smilow Cancer Hospital Care Center - Waterford Waterford Connecticut 06385
Mayo Clinic in Florida Jacksonville Florida 32224-9980
Northwestern University Chicago Illinois 60611
University of Kansas Clinical Research Center Fairway Kansas 66205
HaysMed Hays Kansas 67601
Lawrence Memorial Hospital Lawrence Kansas 66044
The University of Kansas Cancer Center - Olathe Olathe Kansas 66061
University of Kansas Cancer Center-Overland Park Overland Park Kansas 66210
Mercy Hospital Pittsburg Pittsburg Kansas 66762
Salina Regional Health Center Salina Kansas 67401
University of Kansas Health System Saint Francis Campus Topeka Kansas 66606
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536
Mayo Clinic in Rochester Rochester Minnesota 55905
University Health Truman Medical Center Kansas City Missouri 64108
University of Kansas Cancer Center - North Kansas City Missouri 64154
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064
University of Kansas Cancer Center at North Kansas City Hospital North Kansas City Missouri 64116
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon New Hampshire 03756
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03854474, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03854474 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →